Outlook Therapeutics Inc
OTLK - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$63.19M
Close$
$-0.03
106.6% downside
Current Fair Value
106.6% downsideOvervalued by 106.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $63.19 Million |
|---|---|
| Enterprise Value | $51.95 Million |
| Earnings per Share | $-1.79 |
| Beta | 0.75 |
| Outstanding Shares | 136,743,333 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | -67771217.78% |
| Return on Invested Capital | 1256681106.34% |
Valuation & Multiples
| P/E Ratio | -0.43 |
|---|---|
| PEG | 0.43 |
| Price to Sales | 0.0 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.08
Consensus analyst estimateRevenue Estimate
$966,667
Consensus analyst estimateNext Earnings Call
Expected Date
December 18, 2026
EPS Estimate
$-0.08
Consensus analyst estimateRevenue Estimate
$1.77 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 46.89% |
|---|---|
| Total Calls | 100,000▼ 89.88% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.56%▼ 75.98% |
|---|---|
| Total Invested | $520,477▼ 98.38% |
| Investors Holding | 14▼ 64.00% |
About Outlook Therapeutics Inc
8 employees
CEO: Lawrence Kenyon
